VT3989 Emerges as Promising Targeted Therapy for Mesothelioma and Other Solid Tumors
Breakthrough in Hippo Pathway Targeting In a significant development for oncology therapeutics, the YAP/TEAD inhibitor VT3989 has demonstrated promising results…
Breakthrough in Hippo Pathway Targeting In a significant development for oncology therapeutics, the YAP/TEAD inhibitor VT3989 has demonstrated promising results…